Patent intelligence · HU
HU P0204410
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
Patent details — HU P0204410
- Jurisdiction
- HU
- Status
- expired
- Grant date
- May 28, 2003
- Expiration
- May 23, 2023
- Applicant
- SMITHKLINE BEECHAM PLC [GB]
- CPC classes
- A61K 31/ 495 A I, A61K 31/ 505 A I, A61K 31/ 513 A I, A61K 31/ 517 A I
Quick answer
HU P0204410 (PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE) is held by SMITHKLINE BEECHAM PLC [GB]. Status: expired. Granted May 28, 2003. Expires May 23, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SMITHKLINE BEECHAM PLC [GB]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 495 A I, A61K 31/ 505 A I, A61K 31/ 513 A I, A61K 31/ 517 A I, A61P 3/ 06 A I, A61P 3/ 10 A I
More from SMITHKLINE BEECHAM PLC [GB]
Related pharmaceutical patents in our USPTO index.
-
SA 92120308
تركيبة للاستخدام الموضعي topical composition
expired -
AT E269330
CHEMISCHE VERBINDUNGEN
expired -
EP 1425277
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
expired -
SA 91110341
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
expired -
HU P0302480
PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
expired -
AT E245157
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
expired -
HK 1004528
Dentifrice compositions
expired
Frequently asked questions
What is US patent P0204410?
HU P0204410 (PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE) is held by SMITHKLINE BEECHAM PLC [GB]. Status: expired. Granted May 28, 2003. Expires May 23, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns HU P0204410?
SMITHKLINE BEECHAM PLC [GB] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does HU P0204410 expire?
Our index shows an expiration date of May 23, 2023 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.